|
Volumn 16, Issue 5, 2000, Pages 1021-1027
|
A phase III randomized study comparing oral doxifluridine and oral 5-fluorouracil after curative resection of gastric cancer.
a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
DOXIFLURIDINE;
FLOXURIDINE;
FLUOROURACIL;
ADJUVANT CHEMOTHERAPY;
ADULT;
AGED;
ARTICLE;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE FREE SURVIVAL;
FEMALE;
HUMAN;
MALE;
MIDDLE AGED;
ORAL DRUG ADMINISTRATION;
PHASE 3 CLINICAL TRIAL;
RANDOMIZED CONTROLLED TRIAL;
STOMACH TUMOR;
TIME;
TUMOR RECURRENCE;
ADMINISTRATION, ORAL;
ADULT;
AGED;
CHEMOTHERAPY, ADJUVANT;
DISEASE-FREE SURVIVAL;
FEMALE;
FLOXURIDINE;
FLUOROURACIL;
HUMANS;
MALE;
MIDDLE AGED;
NEOPLASM RECURRENCE, LOCAL;
STOMACH NEOPLASMS;
TIME FACTORS;
MLCS;
MLOWN;
|
EID: 0034183163
PISSN: 10196439
EISSN: None
Source Type: Journal
DOI: 10.3892/ijo.16.5.1021 Document Type: Article |
Times cited : (12)
|
References (0)
|